Cybin’s Leap Forward: DMT-Based Therapy Ready for Phase 2 Trials
The TDR Three Key Takeaways Innovative DMT-Based Therapies: Cybin Inc. is evolving psychedelic therapy with CYB004 and SPL028, derived from DMT. These therapies are significant
The TDR Three Key Takeaways Innovative DMT-Based Therapies: Cybin Inc. is evolving psychedelic therapy with CYB004 and SPL028, derived from DMT. These therapies are significant
In this day and age of spiritual tourism, traveling to a psychedelic retreat in Mexico, Jamaica or Peru has become a trendy new habit for
Between Walgreens’ earnings call last week and its J.P. Morgan Healthcare Conference presentation on Monday, it’s becoming clear that the company won’t be acquiring anything
Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug
Nicotine e-cigarettes are more effective in helping people quit smoking than conventional nicotine-replacement therapy (NRT), according to the latest Cochrane review co-led by a University
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Boston Scientific said Monday it
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Tandem Diabetes Care integrated its
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Procedure volumes increased in the
Digital health funding has fallen significantly since the sector’s pandemic-era boom, creating a new normal for investment in the burgeoning sector. Some companies closed their
4Front Ventures Corp. Transforms Balance Sheet Through Conditional Senior Secured Debt Conversion into Equity and Announces Leadership Change PHOENIX, Jan. 8, 2024 /PRNewswire/ – 4Front